Verdict · /v/dividend-vs-growth-stocks-long-run

Run 2026-08-30

The thesis

Dividend stocks are safer than growth stocks over the long run.

How buffet read it

$10,000 split evenly between SCHD (dividend equity) and IWF (Russell 1000 Growth).

2016–2026, rebalanced annually.

Dividends reinvested throughout.

Benchmark: S&P 500.

SCHD 50%, IWF 50% · 2,679 trading days · benchmark SPY

$10,000 became

$0

beat the index+382.6% against +354.3% for the S&P 500, 2016–2026

The same money in the S&P 500 would have been $45,429 over 2016–2026 — the thesis came out ahead by $2,832.

the thesisthe S&P 500growth of one dollar · 2016–2026

The worst stretch

−32.1%, February 2020 to March 2020 — you would have sat through one month of that, and it took until July 2020 to get back to level.

the S&P 500 fell 33.7% at its worst over the same period. The thesis moved 17.2% a year against 17.8% for the index.

Where the thesis was wrong

The portfolio beat the S&P 500 by $2,832 over 2016–2026, ending at $48,260 (+382.6%) against the index's $45,429 (+354.3%). The margin was narrow and depended heavily on IWF, which returned +449.7% against SCHD's +289.6% — the growth half carried the dividend half. The thesis claimed dividends were safer, but the word "safer" does the most work here and this backtest measures only total return, not risk-adjusted performance. SCHD would have dragged the portfolio behind the index on its own, and 2022 showed both halves losing, thesis −16.2% and index −18.2%, with no meaningful shelter from the dividend sleeve.

Counter-test

Same money, same schedule, parked in 1–3 month T-bills instead: $12,518.

Year by year

YearThe thesisSPY
2016+13.3%+13.6%
2017+25.4%+21.7%
2018−3.6%−4.6%
2019+31.6%+31.2%
2020+26.6%+18.4%
2021+28.7%+28.7%
2022−16.2%−18.2%
2023+23.7%+26.2%
2024+22.3%+24.9%
2025+11.3%+17.7%
2026+16.5%+13.4%

What this verdict does not include

  • US-listed stocks and ETFs only, priced on end-of-day closes.
  • No tax, no trading fees, no slippage, no bid-ask spread.
  • Dividends are reinvested, because closes are adjusted for them.
  • Survivorship is not corrected for: only instruments that exist today are held.
  • Only 11 years of history exist for this. Read it accordingly.
  • SCHD is used as the dividend proxy; it launched in late 2011, so the start is set to 2016 for a clean 10-year window.
  • 'Safer' is not directly measurable here — this backtest shows total return only, not volatility, drawdown, or Sharpe ratio.
  • The thesis implies a risk comparison; a full risk-adjusted analysis would require metrics this engine does not compute.

Keep this thesis

buffet re-runs it once a month and mails you the new number. Nothing else is ever sent.

Another thesis

Every verdict names something it could not test. That gap is usually the next thesis.

Run another thesis — $5
What else has been checked$10,000 in · 10.6 years · 2,679 closes